MYL5 and endometrial cancer: MYL5 showed enrichment in pathways related to amino sugar and nucleotide sugar metabolism, butanoate metabolism, cysteine and methionine metabolism, endometrial cancer, metabolism of xenobiotics by cytochrome P450, and retinol metabolism (Figure 7D).